🚀 Less than five months after our launch, we’re excited to announce the release of H-optimus-0, the world’s largest open-source AI foundation model for pathology! With 1.1 billion parameters, H-optimus-0 is trained on a proprietary dataset of several hundreds of millions of images extracted from over 500,000 histopathology slides across 4,000 clinical practices. This sets a new benchmark for state-of-the-art performance in several critical medical diagnostic tasks, from identifying cancerous cells to detecting genetic abnormalities in the tumor. You can access the model, detailed documentation, and research findings on our GitHub repository: https://lnkd.in/gnpxw3wT Read our press release: https://lnkd.in/gPzr47qN
Bioptimus
Recherche en biotechnologie
Paris, Île-de-France 5 851 abonnés
We build foundation models that will transform biology.
À propos
We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology.
- Site web
-
https://www.bioptimus.com/
Lien externe pour Bioptimus
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris, Île-de-France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2024
- Domaines
- artificial intelligence, biology et foundation models
Lieux
-
Principal
Boulevard Poissonnière
Paris, Île-de-France, FR
Employés chez Bioptimus
-
Jean-Philippe Vert
Chief R&D at Owkin / Co-founder at Bioptimus / Use AI to unravel biology and find the right treatment for every patient
-
Edward Kliphuis
Partner at Sofinnova Partners
-
Thomas Clozel
Towards scientific AGI
-
Pierre Entremont
Co-founder & Managing Partner at Frst 💥 I invest at Day One in unique people
Nouvelles
-
H-optimus-0 is now on Hugging Face 🤗 Get ready to access the largest fully open-source foundation model for histopathology, created by Bioptimus. Dive in and explore! https://lnkd.in/eCv8R-sm
-
-
Bioptimus a republié ceci
🚀 Less than five months after our launch, we’re excited to announce the release of H-optimus-0, the world’s largest open-source AI foundation model for pathology! With 1.1 billion parameters, H-optimus-0 is trained on a proprietary dataset of several hundreds of millions of images extracted from over 500,000 histopathology slides across 4,000 clinical practices. This sets a new benchmark for state-of-the-art performance in several critical medical diagnostic tasks, from identifying cancerous cells to detecting genetic abnormalities in the tumor. You can access the model, detailed documentation, and research findings on our GitHub repository: https://lnkd.in/gnpxw3wT Read our press release: https://lnkd.in/gPzr47qN
-
We're excited to sponsor this year's ICML Workshop: “Accessible and Efficient Foundation Models for Biological Discovery.” Join us to explore how Generative AI transforms ideas into reality and closes the gap between machine learning research and unmet medical needs. Learn more about the event: https://lnkd.in/etD5ddfr
-
-
We are excited to announce that Bioptimus has been selected to join the Technology Pioneers 2024 Cohort at the World Economic Forum! At Bioptimus, we are committed to building large-scale AI foundation models for biology and unlocking the next generation of life sciences innovation. We will bring our expertise in AI foundation models and data to the Centre for the Fourth Industrial Revolution. We are pleased to unite with fellow tech pioneers to bring innovative ideas and solutions to the forum. Read more about this year’s cohort here: wef.ch/techpioneers24 #AI #generativeAI #techpioneers24 #wef
-
-
Bioptimus a republié ceci
Chief R&D at Owkin / Co-founder at Bioptimus / Use AI to unravel biology and find the right treatment for every patient
Thank you Minister of State for Digital Affairs of France Marina Ferrari for not only actively supporting the AI tech scene in France but also for proudly showing to the world that the characteristic purple color of Bioptimus logo (and of our website, and of our slide decks, and, who knows, of our future office building?) is nothing to be ashamed of!
Bioptimus co-founders Jean-Philippe Vert, Felipe Llinares-López and Charlie Saillard are at #VivaTech alongside Minister of State for Digital Affairs of France Marina Ferrari. The team has been busy showcasing the potential of #generativeAI in biology to fuel scientific breakthroughs and accelerate the pace of innovation in biomedicine and biotechnology.
-
-
Bioptimus co-founders Jean-Philippe Vert, Felipe Llinares-López and Charlie Saillard are at #VivaTech alongside Minister of State for Digital Affairs of France Marina Ferrari. The team has been busy showcasing the potential of #generativeAI in biology to fuel scientific breakthroughs and accelerate the pace of innovation in biomedicine and biotechnology.
-
-
It’s almost time for #VivaTech! Tomorrow, 22 May at 4:30pm CET stop by the AWS Founders Lounge as Bioptimus co-founder Jean-Philippe Vert joins David Foster and Nikola Mrkšić for a Founders Discussion on Transforming Ideas into Reality: How Generative AI Can Help Startups Succeed. The trio will dive into how the power of Generative AI can transform ideas into reality, streamline operations, enhance customer experiences, and drive innovation. Find out more here: https://lnkd.in/eT4CbDdX
-
-
Bioptimus a republié ceci
Chief R&D at Owkin / Co-founder at Bioptimus / Use AI to unravel biology and find the right treatment for every patient
Fully agree that: - Large-scale AI foundation models for biology are poised to unlock the next generation of biotechnology innovation (go Bioptimus 🚀) - Data is a strategic asset that will require significant private and public investments to support the emergence tomorrow’s champions, also in Europe Emmanuel Macron Marina Ferrari
Atomic AI founder and CEO Raphael Townshend participated in a discussion with Secretary of State Antony J. Blinken during a visit to the Bay Area earlier this week. During the visit, Secretary Blinken met with a panel of industry and policy experts to talk about the nation's biotech and biomanufacturing industries and how they could best contribute to a sustainable, safe and secure American bioeconomy. Raphael shared his insights into the potential of #AI and the need for "strategic data reserves" supported by sustained investment from both the public and private sectors. The Secretary also heard calls for more resilient, sustainable pharmaceutical supply chains, with minimal disruptions to critical drug supplies and equitable access to essential medicines for all. See more here: rb.gy/3utmii #biosecurity #bioeconomy #biomanufacturing #biotech #AI
-
-
Yesterday Zelda Mariet, our Co-founder and Principal Research Scientist, presented at BioIT World on multimodal foundational models for biology. In her talk, she posed the question: can AI help us learn the language of life - connecting DNA, proteins, cells, tissues, and organisms? Learn more at https://lnkd.in/evJh6Z-a
-
Pages similaires
Financement
Dernier round
Mise de fonds initiale35 000 000,00 $US